KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)
Osteoarthritis, Hip
About this trial
This is an interventional treatment trial for Osteoarthritis, Hip focused on measuring total hip arthroplasty
Eligibility Criteria
Inclusion Criteria:
- Male and female participants over age 21 with a compatible smartphone (Apple iPhone 6s or newer running iOS 13 or higher) are eligible to participate.
- Participants must be community ambulatory
Exclusion Criteria:
- Age less than 21.
- Incompatible smartphone device.
- History of neurological injury or pathology.
- Prior total joint athroplasty in the preceding year.
Sites / Locations
- Univrsity of Cincinnati Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
KINCISE
Traditional Mallet
The KINCISE™ Surgical Automated System (KINCISE) (DePuy Synthes Products, Inc, Warsaw, IN) was developed to replace the handheld mallet traditionally used in total hip arthroplasty (THA). The device is an FDA-approved medical instrument. As such, the focus of the study does not relate to the safety and efficacy of the device, which has already been established. Instead, the current IRB proposal investigates whether there are long-term benefits to patient outcomes that differ between KINCISE-guided versus mallet THA.
A traditional mallet will be used during surgery in this group.